By investing wisely, the Foundation helps keep the University in a leadership position for research of all kinds, whether that means supporting one of the country’s finest cancer treatment and research institutions or ensuring our medical professionals receive world-class training in emergency preparedness.
Your contributions support advancements in research, prevention and treatment
The James Graham Brown Cancer Center’s goal of “translational research” means that it facilitates the rapid transfer of promising scientific discoveries from the laboratory to the patient’s bedside. The National Institutes of Health shares our goal, and translational research has been identified as the most important area of medical research for the next decade.
The Brown Cancer Center’s strategic plan for translational research focuses primarily on drug discovery and development. It has one of the most robust pipelines of anti-cancer drugs of any cancer center in the nation. This includes a novel growth inhibitor for cancer that uses G-rich oligonucleotide aptamer therapy. This therapy has been quite effective in early-phase clinical trials. The drug is now demonstrating remarkable cancer- fighting results in Phase II trials.
The economic benefits provided by UofL research affect people around the globe
University of Louisville researchers were primarily responsible for the research that led to the creation of the Gardasil vaccine, which FDA trials proved to be 100% effective in preventing cervical cancer. Today, we continue to refine that research. We are exploring the use of tobacco plants to reduce the cost of the Gardasil vaccine from $350 to $3, making it a reality for developing countries where the disease is far more prevalent. At the same time, the research could spur new industry options for Kentucky’s tobacco farmers.
UofL assists in emergency preparedness
The University has assisted more than 40,000 physicians, nurses, EMS and public health officials in becoming better prepared for national emergencies and health hazards. Researchers at the School of Public Health and Information Sciences’ Center for Health Hazards Preparedness (CHHP) coordinate initiatives and educational opportunities to improve response to potential acts of terrorism, natural disasters and infectious disease. One of these initiatives is the Severe Influenza Pneumonia Surveillance (SIPS) Network study, led by Dr. Julio Ramirez of the UofL School of Medicine. SIPS is a project that brings hospitals across the Commonwealth together to develop and implement a comprehensive surveillance plan for pandemic influenza. This plan incorporates both clinical case-based and laboratory-based surveillance.
During the 2011 fiscal year, the University received $145.6 million in grant funding, including 25 individual awards worth more than $1,000,000 each. UofL also received the distinction of a “very high research activity” classification from the Carnegie Foundation for the Advancementof Teaching.
Excellence in research translates to real-world solutions to the issues and complex problems posed to our communities each and every day. Strong metropolitan research universities are engines for intellectual and economic growth and prosperity, and the Foundation makes the University of Louisville more powerful every day by providing talented researchers with the resources necessary to make breakthroughs that matter.